Regular ArticleIntracerebral Implantation of NGF-Releasing Biodegradable Microspheres Protects Striatum against Excitotoxic Damage
References (73)
- et al.
Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease
Neuroscience
(1997) - et al.
Traumatized rat striatum produces neurite-promoting and neurotrophic activities in vitro
Exp. Neurol.
(1996) - et al.
Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: effect on basal forebrain cholinergic neurons during aging
Neurobiol. Dis.
(1996) Excitotoxic injury of the neostriatum: a model for Huntington's disease
TINS
(1990)- et al.
Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease
Cell Transplant.
(1997) - et al.
Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease
Cell Transplant.
(1998) - et al.
Implanted NGF producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum
Exp. Neurol.
(1994) - et al.
Hyaluronane derivative microspheres as NGF delivery devices: preparation methods and in vitro release characterization
Int. J. Pharm.
(1992) - et al.
NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion
Exp. Neurol.
(1990) - et al.
p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF
Neuron
(1992)
Striatal interneurons: Chemical, physiological and morphological characterization
TINS
(1995)
Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: Trophic effects upon cholinergic and noncholinergic striatal neurons
Neuroscience
(1996)
Bioerosion and biocompatibility of poly(d,l-lactic-co-glycolic acid) implants in brain
J. Control. Release
(1997)
Neuropeptide Y, somatostatin and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: A combined immunocytochemical and enzyme histochemical study
Neuroscience
(1987)
Transport and elimination of recombinant human NGF during long-term delivery to the brain
Brain Res.
(1996)
Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesion of the striatum
Neurosciences
(1995)
Microencapsulated nerve growth factor: Effect on the forebrain neurons following devascularizing cortical lesions
Neurosci. Lett.
(1992)
Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor
Neurochem. Int.
(1993)
Biodegradation and brain tissue reaction to poly( lactide-co-glycolide) microspheres
Biomaterials
(1993)
NGF restores decrease in catalase activity and increase superoxide dismutase and glutathione peroxidase activity in the brain of aged rats
Free Rad. Biol. Med.
(1992)
Optimization of HSA and NGF encapsulation yields in PLGA microparticles
Int. J. Pharm.
(1998)
NGF release from poly(d,l-lactide-co-glycolide) microspheres: Effect of some formulation parameters on encapsulated NGF stability
J. Contr. Release
(1998)
Controlled release of nerve growth factor from a polymeric implant
Brain Res.
(1990)
Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids
Neuroscience
(1991)
In vitro and in vivo degradation of poly(-lactide:glycolide) type microspheres made by solvent evaporation method
Biomaterials
(1989)
High-affinity nerve growth factor receptor (Trk) immunoreactivity is localised in cholinergic neurons of the basal forebrain and striatum in the adult rat brain
Brain Res.
(1993)
Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA
Neuroscience
(1994)
Hypophagia is induced by intracerebroventricular administration of nerve growth factor
Exp. Neurol.
(1991)
Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for ever one year in rat ventricles: behavioral and anatomical consequences
Exp. Neurol.
(1996)
Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils
Neurosci. Lett.
(1992)
Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington's disease
Proc. Natl. Acad. Sci. USA
(1996)
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
J. Neurosci.
(1991)
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Nature
(1986)
Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers
J. Pharm. Pharmacol.
(1995)
Sustained release of nerve growth factor from biodegradable polymer microspheres
Neurosurgery
(1992)
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
Nature
(1976)
Cited by (0)
- 1
To whom reprint requests should be addressed at Service de Neurochirurgie, CHU d'Angers, 49033 Angers Cedex 01, France. Fax: (33) 241 354 508.
Copyright © 2000 Academic Press. All rights reserved.